HUS Group Awards €1.58 Million Craniomaxillofacial Osteosynthesis Materials Contract to Janssen-Cilag

HUS-yhtymä (Helsinki University Hospital Group) has awarded a €1.58 million contract for craniomaxillofacial osteosynthesis materials to Janssen-Cilag Oy. The two-year contract, with two one-year options, covers facial fracture and bone reconstruction materials, paediatric CMF plates, orthognathic plates, and neurosurgical cranial fixation materials for HUS and two other wellbeing services counties.

Introduction

Craniomaxillofacial surgery requires specialised materials for bone fixation and reconstruction. HUS-yhtymä, the Helsinki University Hospital Group, has established a procurement for these essential surgical materials to serve its hospitals and partner wellbeing services counties.

The contract, valued at €1.58 million, has been awarded to Janssen-Cilag Oy. The two-year agreement covers four product families: facial fracture and bone reconstruction materials, paediatric CMF plates (resorbable), orthognathic plates, and neurosurgical cranial fixation materials. The contract serves HUS, Etelä-Karjalan hyvinvointialue, and Päijät-Hämeen hyvinvointialue.

This procurement ensures that surgeons have access to high-quality materials for complex craniomaxillofacial procedures.

Why This Contract Matters

Specialised osteosynthesis materials are essential for craniomaxillofacial surgery, enabling precise bone fixation and reconstruction. This contract ensures the supply of these critical materials to hospitals in southern Finland.

This contract matters because it:

• Supports complex surgery: Provides materials for facial fracture repair and reconstruction
• Serves three regions: HUS, South Karelia, and Päijät-Häme
• Significant value: €1.58 million contract
• Long-term: 2 years + 2 x 1-year options
• Accelerated procedure: Justified by urgency
• Price-focused: Price-only evaluation (100%)
• Specialist supplier: Janssen-Cilag is a major healthcare company
• SME supplier: Janssen-Cilag is classified as an SME

Contract Timeline

• Contract award notice published: 21 August 2026 (OJ S 161/2026)
• Previous notice referenced: 91850ac4-e582-49a5-be92-567b3a1d3cb8-01
• Contract concluded: 1 August 2026
• Coverage start date: Not specified
• Coverage end date: 2 years + 2 x 1-year options (max 4 years)

Contract Overview

HUS-yhtymä conducted an accelerated open procedure for this procurement. The contract covers the supply of craniomaxillofacial osteosynthesis materials across four product families.

Key features include:

• Single lot: Craniomaxillofacial osteosynthesis materials
• Duration: 2 years + 2 x 1-year options (max 4 years)
• Value: €1,580,000
• Evaluation: Price only (100%)
• Procedure: Accelerated open procedure (justified by urgency)
• Winner: Janssen-Cilag Oy
• No subcontracting: Janssen-Cilag will deliver without subcontracting
• Coverage: HUS, South Karelia, and Päijät-Häme wellbeing services counties

Key Contract Details

Detail	Information
Coordinating buyer	HUS-yhtymä (Helsinki University Hospital Group)
Participating buyers	HUS-yhtymä, Etelä-Karjalan hyvinvointialue, Päijät-Hämeen hyvinvointialue
Winning bidder	Janssen-Cilag Oy
Contract subject	Craniomaxillofacial osteosynthesis materials (CPV 33000000)
Procedure type	Accelerated open procedure
Legal basis	EU Directive 2014/24/EU
Awarded value (EUR)	€1,580,000.00
Contract duration	2 years + 2 x 1-year options (max 4 years)
Bids received	3 (all from SMEs)
EU funding	None
Covered by GPA	Yes
Evaluation criteria	Price only (100%)
Subcontracting	No
Winner size	SME

Project Scope

The contract covers craniomaxillofacial osteosynthesis materials across four product families:

Product Families

• 1. Facial Fractures and Bone Reconstructions: Materials for facial fracture repair and bone reconstruction
• 2. Paediatric CMF Plates (Resorbable): Resorbable plates for paediatric craniomaxillofacial surgery
• 3. Orthognathic Plates: Plates for orthognathic surgery (jaw correction)
• 4. Neurosurgical Cranial Fixation Materials: Materials for cranial fixation in neurosurgery

Geographic Coverage

• HUS-yhtymä: Helsinki University Hospital Group (Helsinki region)
• Etelä-Karjalan hyvinvointialue: South Karelia wellbeing services county
• Päijät-Hämeen hyvinvointialue: Päijät-Häme wellbeing services county

Contract Features

• Duration: 2 years + 2 x 1-year options
• Price-only evaluation: Lowest price wins
• Accelerated procedure: Justified by urgency
• Joint procurement: Three buyers collaborating

About the Contracting Authority

HUS-yhtymä (Helsinki University Hospital Group) is Finland's largest hospital group, providing specialised healthcare services to the Helsinki region and beyond. HUS coordinates joint procurements for its hospitals and partner wellbeing services counties.

About the Winning Company

Janssen-Cilag Oy is a Finnish subsidiary of Johnson & Johnson, specialising in pharmaceutical and medical device products. The company is classified as an SME in Finland. Janssen-Cilag supplies a wide range of medical products, including surgical materials for craniomaxillofacial and neurosurgical procedures.

Procurement Analysis

• Procedure: An accelerated open procedure was used, justified by urgency under Finnish procurement law.
• Competition: Three bids were received, all from SMEs.
• Evaluation criteria: Price only (100%). The buyer selected the supplier based solely on price.
• SME participation: All three bidders were SMEs.
• No subcontracting: Janssen-Cilag will deliver without subcontracting.
• Joint procurement: Three buyers collaborated.

Additional Procurement Facts

• The contract is covered by the WTO's Government Procurement Agreement (GPA).
• No EU funds were used for this procurement.
• The procurement was accelerated (justified by urgency).
• No dynamic purchasing system was used.
• No framework agreement was used—this is a direct supply contract.
• Three bids were received, all from SMEs.
• No subcontracting was declared.
• Disputes or review requests fall to the Markkinaoikeus (Market Court) in Finland.
• Supports HUS, South Karelia, and Päijät-Häme wellbeing services counties.

Market & Industry Perspective

The medical device market for craniomaxillofacial and neurosurgical materials is specialised, with a few major global players. Johnson & Johnson (Janssen-Cilag), Stryker, and Medtronic are key suppliers in this sector.

Key trends in this market include:

• Specialist materials: High-quality materials for complex surgery
• Price focus: Public procurement emphasises price
• SME participation: SMEs can compete effectively
• Joint procurement: Collaboration between buyers
• Resorbable materials: Growing demand for biodegradable options

Economic Significance

At €1.58 million, this contract represents a significant procurement for surgical materials in southern Finland. The contract ensures:

• Supply security: Access to essential surgical materials
• Cost efficiency: Competitive procurement ensures value for money
• SME support: Contract awarded to an SME
• Regional coverage: Serves three wellbeing services counties

Future Procurement Opportunities

With the contract now in place, future opportunities include:

• Contract options: 2 x 1-year extension options
• Re-tender: The contract will be re-tendered after 2-4 years
• Other product families: Additional surgical materials
• Other Finnish regions: Similar procurements by other wellbeing services counties

Opportunities for Suppliers

While this contract is awarded, future opportunities exist for medical device suppliers:

• Other Finnish regions: Similar surgical materials procurements
• Subcontracting: Suppliers may find opportunities
• Re-tender: The contract will be re-tendered in the future
• New products: Emerging technologies

What Businesses Should Watch

• Other Finnish wellbeing services counties' surgical materials tenders
• HUS-yhtymä's future procurement notices
• Emerging surgical technologies
• Changes to Finnish healthcare procurement regulations
• Resorbable and biodegradable materials

FinlandTenders Procurement Intelligence

This surgical materials contract is a significant procurement for HUS and its partner regions. Several features stand out:

• Scale: €1.58 million for four product families
• Price focus: Price-only evaluation (100%)
• Accelerated procedure: Justified by urgency
• SME success: Winner is an SME
• Joint procurement: Three buyers collaborating

For suppliers, this procurement highlights the importance of:

• Competitive pricing: Price is the sole criterion (100%)
• Product quality: Meeting clinical requirements
• SME credentials: SMEs can compete effectively
• Joint procurement readiness: Supplying multiple buyers

Supplier Takeaways

• Offer competitive pricing—price is the sole criterion (100%)
• Ensure product quality meets clinical requirements
• Monitor other Finnish wellbeing services counties for similar opportunities
• Develop relationships with HUS and other hospital groups
• Consider SME status as an advantage
• Prepare for re-tendering after 2-4 years

Key Takeaways

• HUS Group awarded a €1.58 million surgical materials contract to Janssen-Cilag
• 4 product families: Facial fractures, Paediatric CMF plates, Orthognathic plates, Cranial fixation
• Serves HUS, South Karelia, and Päijät-Häme wellbeing services counties
• Evaluation: Price only (100%)
• 3 bids received (all from SMEs)
• Duration: 2 years + 2 x 1-year options
• Accelerated procedure
• No EU funding used

Conclusion

This craniomaxillofacial osteosynthesis materials contract represents a significant procurement for HUS and its partner wellbeing services counties. By awarding the contract to Janssen-Cilag Oy, HUS ensures that surgeons have access to high-quality materials for complex facial, orthognathic, and neurosurgical procedures.

The price-only evaluation (100%) reflects the standardised nature of surgical materials, with quality assured through regulatory approvals. The accelerated procedure, justified by urgency, demonstrates the responsiveness of the procurement system to clinical needs.

As Finnish hospital groups continue to procure specialist surgical materials, similar opportunities will arise for medical device suppliers with competitive pricing and strong product portfolios.

Frequently Asked Questions

Q: What is HUS-yhtymä?

Ans: Helsinki University Hospital Group, Finland's largest hospital group, providing specialised healthcare services.

Q: What is the value of the contract?

Ans: €1,580,000.

Q: Who won the contract?

Ans: Janssen-Cilag Oy, a Finnish subsidiary of Johnson & Johnson.

Q: What products are covered?

Ans: Facial fracture materials, paediatric CMF plates (resorbable), orthognathic plates, and neurosurgical cranial fixation materials.

Q: Which regions are covered?

Ans: HUS, Etelä-Karjala, and Päijät-Häme wellbeing services counties.

Q: What were the evaluation criteria?

Ans: Price only (100%).

Q: How long is the contract?

Ans: 2 years with 2 x 1-year options (max 4 years).

Q: Is this contract funded by the EU?

Ans: No, the procurement is not financed with EU funds.

Source: EU Official Journal, Contract Award Notice 578317-2026, OJ S 161/2026, published 21 August 2026.